News & Insights
Sort By
Insights 36 Results
Insights
|September 25, 2025
Client Insight: SEC Opens the Door to Mandatory Shareholder Arbitration
The SEC will permit mandatory shareholder arbitration in public company governance starting September 19, 2025, marking a significant shift in federal securities law claims
Insights
|March 6, 2024
Client Insight: SEC Adopts New SPAC Regulatory Regime
Extension of Traditional IPO Investor Protections to SPAC Transactions Will Significantly Increase Costs, Complexity and Potential Liability for Market Participants Throughout the SPAC Lifecycle
Insights
|December 22, 2023
Public Companies Insight: Fifth Circuit Panel Vacates SEC’s New Share Repurchase Disclosure Rules
On December 19, 2023, a panel of the U.S. Court of Appeals for the Fifth Circuit vacated the share repurchase disclosure rules adopted by the U.S. Securities and Exchange Commission (SEC) in May 2023. Learn more here.
Events 1 result
Events
|March 11, 2022
Alexa Belonick moderated the “Investor Perspective: IPO Preparation and Readiness” panel, featuring Natasha Shervani (OrbiMed) and Chris Cornforti (Altimeter).
Client News 28 Results
Client News
|November 6, 2025
Gunderson Dettmer represented long-time client BillionToOne, Inc. (Nasdaq: BLLN), a molecular diagnostics company on a mission to make powerful and accessible genetic tests available to all, in its initial public offering of 4.6 million shares of Class A common stock at a price to the public of $60 per share, generating approximately $273.1 billion in aggregate gross proceeds.
Client News
|November 5, 2025
Gunderson Dettmer Represented Aeva in $100M Investment from Apollo
Aeva Technologies, a leader in next-generation sensing and perception systems, announces Apollo’s purchase of $100 million in aggregate principal amount of 4.375% convertible senior notes due 2032.
Client News
|November 3, 2025
Leerink Partners and Goldman Sachs & Co. LLC served as representatives of the underwriters in the common stock offering of Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on creating best-in-class therapies.
Firm News 26 Results
Firm News
|August 6, 2025
Joyce Hu Joins Gunderson Dettmer Beijing as Of Counsel
We are delighted to announce that Joyce Hu has joined our Beijing office as Of Counsel. Joyce is a valued member of our China and Life Sciences practice groups, where she focuses on representing emerging growth companies in the life sciences and technology sectors throughout their corporate lifecycles.
Firm News
|March 4, 2025
PitchBook 2024 Annual Global League Tables Confirms Gunderson Dettmer as #1 VC Law Firm Globally
For the 11th consecutive year, Gunderson Dettmer has been named the most active VC law firm globally by the 2024 PitchBook Global League Tables.
Firm News
|September 5, 2024
Gunderson Dettmer Generative AI Resources
Gunderson Dettmer fuels Generative AI education in venture capital. Explore diverse AI resources: articles, client insights, events, podcasts, and webinars – all enhancing your engagement with this dynamic field.
Blog Posts 2 Results
Public Ventures
|September 25, 2025
Client Insight: SEC Opens the Door to Mandatory Shareholder Arbitration
Public Ventures
|March 6, 2024
Client Insight: SEC Adopts New SPAC Regulatory Regime
Extension of Traditional IPO Investor Protections to SPAC Transactions Will Significantly Increase Costs, Complexity and Potential Liability for Market Participants Throughout the SPAC Lifecycle
